Paper Details

  1. Home
  2. Paper Details

Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries.

Author: HavanondPiyalamporn, KhemapechNipon, KhorprasertChonlakiet, LertmaharitSomrat, PongpanichSathirakorn, TaneepanichskulSurasak, TermrungruanglertWichai

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Prophylactic HPV vaccination in girls is likely to be cost-effective in Thailand. The model showed a significant reduction in mortality, incidence of cervical cancer, cervical intraepithelial neoplasia, and genital warts.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Approximately 80% of cervical cancer cases occur in developing countries. In Thailand, cervical cancer has been the leading cancer in females, with an incidence of 24.7 cases per 100,000 individuals per year. OBJECTIVES: We constructed a decision model to simulate the lifetime economic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jval.2011.11.007

データ提供：米国国立医学図書館（NLM）

HPV Vaccination: A Cost-Effective Investment for Women's Health

The global burden of cervical cancer, a disease often preventable through vaccination, poses a significant health threat to women worldwide. This study, published in 2012, investigates the cost-effectiveness of prophylactic HPV vaccination in developing countries, specifically focusing on the Thai context. The researchers developed a decision model to simulate the long-term economic impact of HPV vaccination for women, considering the incidence and cost of HPV-related diseases, such as cervical cancer, cervical intraepithelial neoplasia, and genital warts.

HPV Vaccination: A Valuable Investment

The study found that prophylactic HPV vaccination was highly cost-effective in the Thai context, significantly reducing the incidence of HPV-related diseases and improving overall health outcomes for women. The findings suggest that nationwide HPV vaccination programs could offer a substantial return on investment, improving public health and saving lives. Imagine HPV vaccination as a life-saving oasis in the desert of cervical cancer, protecting women from the devastating consequences of this disease.

A Path Toward Better Health

This study highlights the cost-effectiveness of HPV vaccination, urging policymakers and healthcare providers to prioritize this preventive measure. The findings underscore the importance of investing in public health initiatives that can protect women from preventable diseases, improving their overall health and well-being. This is a journey through the desert of public health, seeking to improve the lives of women and create a healthier future for generations to come.

Dr.Camel's Conclusion

This study provides compelling evidence for the cost-effectiveness of HPV vaccination in developing countries. The findings highlight the potential of this preventive measure to significantly reduce the burden of cervical cancer and improve health outcomes for women. This is a testament to the power of investing in public health initiatives that can protect individuals and communities from preventable diseases. This is a journey through the desert of public health, seeking to create a healthier and more equitable world for all.

Date :
  1. Date Completed 2012-03-20
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

22265063

DOI: Digital Object Identifier

10.1016/j.jval.2011.11.007

Related Literature

Article Analysis
・Causes of genital warts
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.